Gladius Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-2,645
Closed -$20.9K – 244
2024
Q3
$20.9K Buy
+2,645
New +$23.8K ﹤0.01% 271
2024
Q1
– Sell
-4,216
Closed -$64.7K – 414
2023
Q4
$64.7K Sell
4,216
-4,518
-52% -$63.1K 0.01% 167
2023
Q3
$128K Buy
+8,734
New +$136K 0.01% 190
2022
Q4
– Sell
-10,748
Closed -$206K – 437
2022
Q3
$206K Buy
10,748
+6,753
+169% +$137K 0.01% 147
2022
Q2
$72K Buy
3,995
+1,153
+41% +$27.1K ﹤0.01% 223
2022
Q1
$83K Sell
2,842
-199
-7% -$5.47K 0.01% 238
2021
Q4
$85K Buy
+3,041
New +$86K 0.01% 267

Other funds holding TBI

Gladius Capital Management's TBI Position: Q4 2024 in Review

Gladius Capital Management sold out of Trueblue (TBI) in Q4 2024, closing a stake of 2,645 shares — an estimated $20.9K sold.

Gladius Capital Management first reported a position in TBI in Q4 2021 and held it in 7 quarters. The position peaked at $206K in Q3 2022. 117 funds tracked by Wall St. Rank hold TBI as of Q4 2024.

  • Gladius Capital Management reported no remaining Trueblue position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 2,645 Trueblue shares in Q4 2024, an estimated $20.9K.
  • Gladius Capital Management first reported a position in Trueblue in Q4 2021 and held it in 7 quarters.
  • Gladius Capital Management's Trueblue position peaked at $206K in Q3 2022.
  • 117 funds tracked by Wall St. Rank held Trueblue as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.